Scope of the Study
Flow cytometer detects the characteristics of population of cells or particle such as cell size, count, and cycle. The expression of surface and intracellular molecules is analyzed by this method. The flow cytometer provides specific information about the cells. Further, it uses the light to count the cells and profile it in a fluid mixture. Also, the series of sensors that are used to detect the light which is refracted from the cells. Then, the data acquired is compiled and used to build an image. The increasing usage of flow Cytometry for clinical laboratory is creating a demand for flow cytometer.
The market study is being classified, by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation and Hematology) and major geographies with country level break-up.
Becton Dickinson (United States), Beckman Coulter (United States), Merck KGaA (Germany), Partec GMBH (Germany), Thermo Fisher (United States), Luminex Corp (United States), Miltenyi Biotec (Germany), Intellicyt Corp (United States), Sony (Japan) and Apogee Flow Systems (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Advanced Analytical (United States), GE Healthcare (United States) and Union Biometrica (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Flow Cytometers market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Flow Cytometers market by Type, Application and Region.
On the basis of geography, the market of Flow Cytometers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Clinical Trials is Fueling the Market Growth
- Increasing Need of Faster and Accurate Cancer Prognostic Tools
- Adoption of Flow Cytometer for Research and Development
- Increasing Awareness for Cell Based Assays
- High Costs of Equipment in Developing Economies
- Government Initiatives for the Research and Development for Health Care
- Rising Biotechnology Sector
- Lack of Awareness among the End Users
Market Leaders and their expansionary development strategies
In May 2019, Merck has acquired intermolecular Inc. which has a capability in rapid material screening.
In August 2019, Sysmex has launched PS10 Sample preparation system. It provides more efficient workflows and aids in standardizing flow cytometer testing.
Key Target AudienceManufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase